Citation: F. Rabbani et al., Upper-tract tumors after an initial diagnosis of bladder cancer: Argument for long-term surveillance, J CL ONCOL, 19(1), 2001, pp. 94-100
Citation: F. Rabbani, Some observations on the morphology and structure of high temperature oxides formed on three superalloys as a result of the superficial application of Ce(SO4)(2), SURF COAT, 140(2), 2001, pp. 67-75
Authors:
Rabbani, F
Sheinfeld, J
Farivar-Mohseni, H
Leon, A
Rentzepis, MJ
Reuter, VE
Herr, HW
McCaffrey, JA
Motzer, RJ
Bajorin, DF
Bosl, GJ
Citation: F. Rabbani et al., Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse, J CL ONCOL, 19(7), 2000, pp. 2020-2025
Citation: F. Rabbani et C. Cordon-cardo, Mutation of cell cycle regulators and their impact on superficial bladder cancer, UROL CLIN N, 27(1), 2000, pp. 83
Citation: F. Rabbani et al., Second primary malignancies associated with renal cell carcinoma: Influence of histologic type, UROLOGY, 56(3), 2000, pp. 399-403
Citation: F. Rabbani et al., A comparison of the growth kinetics and scale morphology for three superalloys at 930 degrees C in air and low P-O2 environments, OXID METAL, 54(1-2), 2000, pp. 139-153
Authors:
Perrotti, M
Han, KR
Epstein, RE
Kennedy, EC
Rabbani, F
Badani, K
Pantuck, AJ
Weiss, RE
Cummings, KB
Citation: M. Perrotti et al., Re: Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: A pilot study -Reply, J UROL, 163(6), 2000, pp. 1894-1894
Authors:
Rabbani, F
Richon, VM
Orlow, I
Lu, ML
Drobnjak, M
Dudas, M
Charytonowicz, E
Dalbagni, G
Cordon-Cardo, C
Citation: F. Rabbani et al., Prognostic significance of transcription factor E2F-1 in bladder cancer: Genotypic and phenotypic characterization, J NAT CANC, 91(10), 1999, pp. 874-881
Authors:
Fair, WR
Rabbani, F
Bastar, A
Betancourt, J
Citation: Wr. Fair et al., Neoadjuvant hormone therapy before radical prostatectomy: Update on the memorial Sloan-Kettering Cancer Center trials, MOL UROL, 3(3), 1999, pp. 253-260
Authors:
Perrotti, M
Han, KR
Epstein, RE
Kennedy, EC
Rabbani, F
Badani, K
Pantuck, AJ
Weiss, RE
Cummings, KB
Citation: M. Perrotti et al., Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: A pilot study, J UROL, 162(4), 1999, pp. 1314-1317
Authors:
Balaji, KC
Rabbani, F
Tsai, H
Bastar, A
Fair, WR
Citation: Kc. Balaji et al., Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance, J UROL, 162(3), 1999, pp. 753-757
Authors:
Rabbani, F
Perrotti, M
Bastar, A
Fair, WR
Citation: F. Rabbani et al., Prostate specific antigen doubling time after radical prostatectomy: Effect of neoadjuvant androgen deprivation therapy, J UROL, 161(3), 1999, pp. 847-852
Authors:
Orlow, I
LaRue, H
Osman, I
Lacombe, L
Moore, L
Rabbani, F
Meyer, F
Fradet, Y
Cordon-Cardo, C
Citation: I. Orlow et al., Deletions of the INK4A gene in superficial bladder tumors - Association with recurrence, AM J PATH, 155(1), 1999, pp. 105-113
Citation: Wr. Fair et al., Pathologic stage and biochemical recurrence after radical prostatectomy and neoadjuvant hormone therapy: Effect of treatment until PSA is undetectable, MOL UROL, 2(3), 1998, pp. 135-139
Authors:
Rabbani, F
Dalbagni, G
Bastar, A
Fair, WR
Citation: F. Rabbani et al., Nomograms to predict pathologic results of radical prostatectomy: Effect of neoadjuvant hormone therapy, MOL UROL, 2(3), 1998, pp. 143-150
Citation: F. Rabbani et al., Neoadjuvant hormone therapy before radical prostatectomy: Update on Phase II and III Memorial Sloan-Kettering Cancer Center trials, MOL UROL, 2(3), 1998, pp. 151-156
Authors:
Pienta, KJ
Roach, M
Moul, J
Rabbani, F
Trachtenberg, J
Goldenberg, L
McLeod, D
Citation: Kj. Pienta et al., Neoadjuvant hormone therapy before radical prostatectomy: Update on Phase II and III Memorial Sloan-Kettering Cancer Center trials - Discussion, MOL UROL, 2(3), 1998, pp. 157-157
Authors:
Goldenberg, L
Schulman, CC
Fair, WR
Gleave, M
Garnick, MB
Bostwick, D
Grignon, D
Rabbani, F
Citation: L. Goldenberg et al., Results of a European randomized study comparing radical prostatectomy andradical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3NoMo prostatic carcinoma - Open discussion, MOL UROL, 2(3), 1998, pp. 187-187